EASL-AASLD modified Delphi consensus of 62 international panellists agreed 16 statements and 42 recommendations on surrogate endpoints, real-world evidence and patient-reported outcomes to support drug approval in primary biliary cholangitis.
Guidelinen = 62 panellists
European Association for the Study of the Liver et al. EASL-AASLD Delphi consensus statement on surrogate endpoints and real-world evidence in primary biliary cholangitis